314 related articles for article (PubMed ID: 23432792)
41. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
Abo-Zenah H; Moharram M; El Nahas AM
Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209
[TBL] [Abstract][Full Text] [Related]
42. Current observations on sickle cell genotype in Nigeria.
Nduka N; Owhochuku SM; Odike P
East Afr Med J; 1993 Oct; 70(10):646-9. PubMed ID: 7514527
[TBL] [Abstract][Full Text] [Related]
43. Early urinary markers of target nephron segments as studied in cadmium toxicity.
Fels LM; Bundschuh I; Gwinner W; Jung K; Pergande M; Graubaum HJ; Price RG; Taylor SA; De Broe ME; Nuyts GD
Kidney Int Suppl; 1994 Nov; 47():S81-8. PubMed ID: 7869678
[TBL] [Abstract][Full Text] [Related]
44. [Anatomical and pathophysiological bases of renal disorders in sickle cell syndrome patients and carriers of the trait].
Galacteros F
Bull Eur Physiopathol Respir; 1983; 19(4):351-5. PubMed ID: 6354309
[TBL] [Abstract][Full Text] [Related]
45. Value of SDS-polyacrylamide gel electrophoresis, small molecular weight proteins and alpha-1-acid glycoprotein for the diagnosis of tubular damage.
Lubec D; Grillenberger A; Weninger M; Lubec G
Padiatr Padol; 1987; 22(4):319-24. PubMed ID: 2449647
[TBL] [Abstract][Full Text] [Related]
46. Transport proteins and acute phase reactant proteins in children with sickle cell anemia.
Warrier RP; Kuvibidila S; Gordon L; Humbert J
J Natl Med Assoc; 1994 Jan; 86(1):33-9. PubMed ID: 7512147
[TBL] [Abstract][Full Text] [Related]
47. Prevalence, treatment, and outcomes of renal conditions in pediatric sickle cell disease.
Stallworth JR; Tripathi A; Jerrell JM
South Med J; 2011 Nov; 104(11):752-6. PubMed ID: 22024785
[TBL] [Abstract][Full Text] [Related]
48. Renal abnormalities in sickle cell disease.
Allon M
Arch Intern Med; 1990 Mar; 150(3):501-4. PubMed ID: 2178577
[TBL] [Abstract][Full Text] [Related]
49. Urinary excretion of low molecular weight proteins in patients with pure monoclonal light chain proteinuria.
Madalena L; Facio ML; Angerosa M; Pandolfo M; Bresciani P; Alejandre M; Pizzolato M; Toblli JE
J Nephrol; 2007; 20(6):683-8. PubMed ID: 18046670
[TBL] [Abstract][Full Text] [Related]
50. Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease.
Field JJ; Strunk RC; Knight-Perry JE; Blinder MA; Townsend RR; DeBaun MR
Am J Hematol; 2009 Apr; 84(4):231-3. PubMed ID: 19291727
[TBL] [Abstract][Full Text] [Related]
51. Renal abnormalities in sickle cell disease.
Ataga KI; Orringer EP
Am J Hematol; 2000 Apr; 63(4):205-11. PubMed ID: 10706765
[TBL] [Abstract][Full Text] [Related]
52. Serum and urinary amino acid levels in sickle cell disease.
VanderJagt DJ; Kanellis GJ; Isichei C; Patuszyn A; Glew RH
J Trop Pediatr; 1997 Aug; 43(4):220-5. PubMed ID: 9283125
[TBL] [Abstract][Full Text] [Related]
53. Effect of renal insufficiency on the concentration of free retinol-binding protein in urine and serum.
Bernard A; Vyskocyl A; Mahieu P; Lauwerys R
Clin Chim Acta; 1988 Jan; 171(1):85-93. PubMed ID: 3280169
[TBL] [Abstract][Full Text] [Related]
54. Sickle cell nephropathy - a practical approach.
Sharpe CC; Thein SL
Br J Haematol; 2011 Nov; 155(3):287-97. PubMed ID: 21902687
[TBL] [Abstract][Full Text] [Related]
55. Sickle cell haemoglobinopathy and Salmonella osteomyelitis in the eastern province of Saudi Arabia.
Al-Awamy B; Wilson WA; Esmail SM; Abu-Nawarig M
Trop Geogr Med; 1982 Mar; 34(1):51-4. PubMed ID: 7080188
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease.
Wigfall DR; Ware RE; Burchinal MR; Kinney TR; Foreman JW
J Pediatr; 2000 Jun; 136(6):749-53. PubMed ID: 10839871
[TBL] [Abstract][Full Text] [Related]
57. [Spectrum of renal manifestations in sickle cell disease].
Cazenave M; Koehl B; Nochy D; Tharaux PL; Audard V
Nephrol Ther; 2014 Feb; 10(1):10-6. PubMed ID: 24113202
[TBL] [Abstract][Full Text] [Related]
58. Preliminary study on the role of virtual touch tissue quantification combined with a urinary β2-microglobulin test on the early diagnosis of gouty kidney damage.
Tian F; Wang ZB; Meng DM; Liu RG; Zhang HY; Li HY; Lv FF
Ultrasound Med Biol; 2014 Jul; 40(7):1394-9. PubMed ID: 24642221
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for sodium valproate-induced renal tubular dysfunction.
Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
[TBL] [Abstract][Full Text] [Related]
60. Renal tubular dysfunction in patients with primary Sjögren syndrome.
Duffles Amarante GB; Zotin MC; Rocha E; Delgado AG; Leite M; Gomes CP
Clin Nephrol; 2014 Mar; 81(3):185-91. PubMed ID: 24424087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
